| P50 | author | Michael R Sperling | Q62092135 |
| P2093 | author name string | Pavel Klein | |
| | Julia Tsai | |
| P2860 | cites work | Neurosteroids: endogenous role in the human brain and therapeutic potentials | Q24632113 |
| | Neurosteroid replacement therapy for catamenial epilepsy | Q24643667 |
| | Proposal for revised clinical and electroencephalographic classification of epileptic seizures. From the Commission on Classification and Terminology of the International League Against Epilepsy | Q28273764 |
| | Ganaxolone improves behavioral deficits in a mouse model of post-traumatic stress disorder | Q30428666 |
| | Neurosteroids as endogenous regulators of seizure susceptibility and use in the treatment of epilepsy. | Q34065134 |
| | GABAA receptor modulation by neurosteroids in models of temporal lobe epilepsies | Q34315862 |
| | Allopregnanolone analogs that positively modulate GABA receptors protect against partial seizures induced by 6-Hz electrical stimulation in mice | Q34330640 |
| | Antiepileptic drug interactions - principles and clinical implications | Q34402188 |
| | Neuropeptides as targets for the development of anticonvulsant drugs. | Q34413859 |
| | Initial human experience with ganaxolone, a neuroactive steroid with antiepileptic activity | Q34467392 |
| | Ganaxolone | Q34596795 |
| | Clinical evaluation of ganaxolone in pediatric and adolescent patients with refractory epilepsy | Q34651475 |
| | Efficacy and safety of oral lacosamide as adjunctive therapy in adults with partial-onset seizures | Q34652020 |
| | Clinically relevant drug interactions with antiepileptic drugs | Q35827491 |
| | Do structural changes in GABA neurons give rise to the epileptic state? | Q36253373 |
| | Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability | Q37320505 |
| | Altered expression of δGABAA receptors in health and disease | Q38240381 |
| | Adjunctive brivaracetam for refractory partial-onset seizures: a randomized, controlled trial. | Q42997736 |
| | Assessment of ganaxolone's anticonvulsant activity using a randomized, double-blind, presurgical trial design. Ganaxolone Presurgical Study Group. | Q46039957 |
| | Randomized, controlled, dose-ranging trial of carisbamate for partial-onset seizures | Q46253170 |
| | Development and cross-cultural translations of a 31-item quality of life in epilepsy inventory | Q47762611 |
| | Ganaxolone for treating intractable infantile spasms: a multicenter, open-label, add-on trial. | Q51372905 |
| | Eslicarbazepine Acetate: A Double-blind, Add-on, Placebo-controlled Exploratory Trial in Adult Patients with Partial-onset Seizures | Q59284846 |
| P433 | issue | 4 | |
| P921 | main subject | placebo | Q269829 |
| P304 | page(s) | 558-564 | |
| P577 | publication date | 2017-02-23 | |
| P1433 | published in | Epilepsia | Q5382969 |
| P1476 | title | Randomized, double-blind, placebo-controlled phase 2 study of ganaxolone as add-on therapy in adults with uncontrolled partial-onset seizures | |
| P478 | volume | 58 | |